Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
ADNTRO GENETICS logo — Love your DNA 🧬

ADNTRO GENETICS

Love your DNA 🧬

Founded 2020 Spain Spain 15 employees Seed Biopharma, Health Care

General Information

Company Name ADNTRO GENETICS
Founded Year 2020
Location Spain Spain
Employees 15
Industries Biopharma, Health Care
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with ADNTRO GENETICS. To contact ADNTRO GENETICS, visit adntro.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ADNTRO GENETICS compare?

A PDF of ADNTRO GENETICS and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ADNTRO GENETICS soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ADNTRO GENETICS

Adntro Genetics is a cutting-edge startup focused on genetic progress, with a vision to make understanding one's unique genetic code accessible to everyone. Founded in 2020 and based in Spain, the company operates in the Biopharma and Health Care industries, with a commitment to navigating the expanding landscape of genetic information and scientific advancements. The company's slogan, "Love your DNA 🧬," encapsulates its mission to inspire new ideas and scientific approaches through the exploration of genetic data. The completion of the human genetic code in 2003 has sparked an exponential growth in studies and information on genetic markers, driving a deeper understanding of genotype-phenotype relationships. Adntro Genetics aims to aid individuals in keeping up with these developments and making informed decisions about their genetic makeup. Notably, the startup secured a Seed Round investment on 01 May 2022, with Addendum Capital as the investor. This investment underscores the confidence of Addendum Capital in Adntro Genetics’ potential to make a lasting impact in the genetic research and healthcare sectors. As the company continues to progress, its innovative approach and strategic positioning make it a compelling prospect for investors seeking opportunities in the rapidly evolving field of genetic science.

Business keywords: Genetic Progress, DNA Education, Genetic Data Analysis, Bioinformatics, Genetic Research, Polygenic Risk Scores, Genetic Markers, GWAS, Nutrigenomics, Healthcare Innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 1
Addendum Capital
Addendum Capital
01 May 2022

ADNTRO GENETICS Alternatives & Competitors

View All Alternatives
ADNTRO GENETICS vs
Genomics
Genomics United Kingdom

Transforming health, healthcare and drug discovery and development through the power of genomics

186 employees
Biopharma, Biotechnology
ADNTRO GENETICS vs
Cipherome, Inc
Cipherome, Inc United States

AI-driven data analysis platform enhancing healthcare research with predictive analytics, cohort que...

Series B
12 employees
Biopharma, Biotechnology
ADNTRO GENETICS vs
Oxford Nanopore Technologies
Oxford Nanopore Technologies United Kingdom

Our goal is to enable the analysis of anything, by anyone, anywhere.

Post-IPO Equity
1341 employees
Biopharma, Biotechnology
View all alternatives

FAQ About ADNTRO GENETICS

Love your DNA 🧬
ADNTRO GENETICS was founded in 2020.
ADNTRO GENETICS is headquartered in Spain.
ADNTRO GENETICS operates in Biopharma and Health Care. Its work centres on Genetic Progress, DNA Education, Genetic Data Analysis and Bioinformatics.
ADNTRO GENETICS has approximately 15 employees.
ADNTRO GENETICS has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to ADNTRO GENETICS include Genomics, Cipherome, Inc, Oxford Nanopore Technologies, Sano Genetics, Gordion Bioscience. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ADNTRO GENETICS and Genomics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ADNTRO GENETICS, https://bouncewatch.com/company/adntro-genetics, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes